** Shares of Zoono Group Ltd ZNO.AX rise as much as 15.38%
to A$0.150, their highest since Aug. 15
** The antibacterial technology co says it's entering into a
co-development and licence agreement with Douglas
Pharmaceuticals, a NZ-based private pharma co
**Co and Douglas will work closely together to develop and
commercialise Zoono-based specialty products, with a nasal spray
being the first
** Stock posts its biggest intraday pct gain since July 8
** More than 319,000 shares change hands vs the 30-day
average volume of 149,000 shares
** Stock has fallen 65.79% this year, as of last close
(Reporting By Udbhav Krishna P in Bengaluru)
((UdbhavKrishna.P@Thomsonreuters.com))